ACDCRGDCFCG (DISULFIDE BRIDGE: 2-10 AND 4-8)
ACDCRGDCFCG (DISULFIDE BRIDGE: 2-10 AND 4-8) Basic information
- Product Name:
- ACDCRGDCFCG (DISULFIDE BRIDGE: 2-10 AND 4-8)
- Synonyms:
-
- ACDCRGDCFCG (DISULFIDE BRIDGE: 2-10 AND 4-8)
- H-ALA-CYS-ASP-CYS-ARG-GLY-ASP-CYS-PHE-CYS-GLY-OH (DISULFIDE BRIDGE: 2-10 AND 4-8)
- ALA-CYS-ASP-CYS-ARG-GLY-ASP-CYS-PHE-CYS-GLY(DISULFIDE BRIDGE:CYS2-CYS10, CYS4-CYS8)
- RGD-4C
- H-Ala-Cys-Asp-Cys-Arg-Gly-Asp-Cys-Phe-Cys-Gly-OH(Cys2-Cys10 , Cys4-Cys8)
- Glycine, L-alanyl-L-cysteinyl-L-α-aspartyl-L-cysteinyl-L-arginylglycyl-L-α-aspartyl-L-cysteinyl-L-phenylalanyl-L-cysteinyl-, cyclic (2→10),(4→8)-bis(disulfide)
- CAS:
- 332179-76-7
- MF:
- C42H60N14O16S4
- MW:
- 1145.27
- Product Categories:
-
- Peptide
- Mol File:
- Mol File
ACDCRGDCFCG (DISULFIDE BRIDGE: 2-10 AND 4-8) Chemical Properties
- Density
- 1.69±0.1 g/cm3(Predicted)
- pka
- 3.57±0.10(Predicted)
- form
- Solid
- color
- White to off-white
ACDCRGDCFCG (DISULFIDE BRIDGE: 2-10 AND 4-8) Usage And Synthesis
Uses
RGD-4C is a arginine-glycine-aspartic acid peptide (ACDCRGDCFC) with integrin binding activity. The Arg-Gly-Asp (RGD) sequence serves as the primary integrin recognition site in extracellular matrix proteins, and peptides containing this sequence can mimic the recognition specificity of the matrix proteins. RGD-4C is a αv-integrin ligand, can conjugate with bioactive molecule to exert antitumor effects in animal models[1][2][3].
in vivo
RGD-4C (9.11 mg/kg; injection; single dose) inhibits the growth of B16F10 mouse melanoma in vivo[2].
Modified RGD-4C fused with the N-terminus of plant-derived single-chain ribosome inactivating protein saporin (SAP) (called RGD-SAP), (diluted in sodium chloride, 0.9%; i.v.; 200 μL; every 5 days, for 3 times) exerts anti-tumor activity in a model of muscle invasive bladder cancer[3].
RGD-SAP in combination with mitomycin C, a chemotherapeutic drug, increases the survival of mice bearing orthotopic bladder cancer with no evidence of systemic toxicity[3].
References
[1] Assa-Munt N, et al. Solution structures and integrin binding activities of an RGD peptide with two isomers. Biochemistry. 2001 Feb 27;40(8):2373-8. DOI:10.1021/bi002101f
[2] Yin R, et al. Effect of RGD-4C position is more important than disulfide bonds on antiangiogenic activity of RGD-4C modified endostatin derived synthetic polypeptide. Bioconjug Chem. 2010 Jul 21;21(7):1142-7. DOI:10.1021/bc900292y
[3] Zuppone S, et al. A Novel RGD-4C-Saporin Conjugate Inhibits Tumor Growth in Mouse Models of Bladder Cancer. Front Oncol. 2022 Apr 11;12:846958. DOI:10.3389/fonc.2022.846958
ACDCRGDCFCG (DISULFIDE BRIDGE: 2-10 AND 4-8)Supplier
- Tel
- 21-61263452 13641803416
- ymbetter@glbiochem.com
- Tel
- 1-631-485-4226; 16314854226
- info@bocsci.com
- Tel
- info@creative-peptides.com
- Tel
- 021-QQ：65489617 15618227136
- Sales@ATKchemical.com
- Tel
- 17705183659
- sales@njleonbiotech.com